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Abstract 17 
Study hypothesis: High oxygen tension and high medium glucose concentrations dysregulate 18 
p66Shc expression and function during mouse preimplantation embryo culture. 19 
Study finding: P66Shc expression abnormally increases and oxidative phosphorylation 20 
metabolism is impaired in blastocysts produced in culture. 21 
What is known already: Growth in culture adversely impacts preimplantation embryo 22 
development and alters the expression levels of the oxidative stress adaptor protein p66Shc, but 23 
it is not known if p66Shc expression differences are linked to metabolic changes observed in 24 
cultured embryos.  25 
Study design, samples/materials, methods: We used a standard wild type CD1 mouse model of 26 
preimplanation embryo development and embryo culture to modulate atmospheric oxygen 27 
tension and glucose media concentrations. Changes to p66Shc expression in mouse blastocysts 28 
were measured using RT-qPCR, immunoblotting, and immunofluorescence with confocal 29 
microscopy. Changes to oxidative phosphorylation metabolism were measured by total ATP 30 
content and superoxide production. Statistical analyses were performed on a minimum of three 31 
experimental replicates using Students’ t-test or one-way ANOVA. 32 
Main results and the role of chance: P66Shc is basally expressed during in vivo mouse 33 
preimplantation development. Within in vivo blastocysts, p66Shc is primarily localized to the 34 
cell periphery of the trophectoderm. Blastocysts cultured under atmospheric oxygen levels have 35 
significantly increased p66Shc transcript and protein abundances compared to in vivo controls (p 36 
< 0.05). However, phosphorylated serine 36 (S36) p66Shc to total p66Shc ratio decreased under 37 
culture regardless of O2 atmosphere used, supporting a shift in the mitochondrial fraction of 38 
p66Shc. Total p66Shc localized to the cell periphery of the blastocyst trophectoderm and 39 
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phosphorylated S36 p66Shc displayed nuclear and cytoplasmic immunoreactivity, suggesting 40 
distinct compartmentalization of phosphorylated S36 p66Shc and the remaining p66Shc fraction. 41 
Glucose medium concentration did not significantly affect p66Shc expression or its localization. 42 
Blastocysts cultured under low or high oxygen conditions exhibited significantly decreased 43 
cellular ATP and increased superoxide production compared to in vivo derived embryos (p < 44 
0.05). 45 
Limitations, reasons for caution: This study associates embryonic p66Shc expression levels 46 
with metabolic abnormalities but does not directly implicate p66Shc in metabolic changes.  47 
Wider implications of the findings: This is the first study to show distinct immunolocalization 48 
of p66Shc to the trophectoderm of blastocysts and that its levels are abnormally increased in 49 
embryos exposed to culture conditions. Changes to p66Shc expression and/or localization could 50 
serve as a molecular marker of embryo viability for clinical applications. The outcomes provide 51 
insight into the potential metabolic role of p66Shc. Metabolic anomalies are induced even under 52 
current best culture conditions, which could negatively impact trophectoderm and placental 53 
development. 54 
Large scale data: Not applicable. 55 
Study funding and competing interest(s): Canadian Institutes of Health Research (CIHR) 56 
operating funds, Ontario Graduate Scholarship.  There are no competing interests. 57 
 58 
Key words: blastocyst; embryo culture; metabolism; mitochondria; p66Shc; preimplantation 59 
embryo; ROS, stress adaptor  60 
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Introduction 62 
In assisted reproductive technologies (ARTs), embryo culture routinely follows in vitro 63 
fertilization (IVF) to permit growth to the blastocyst stage. Despite improvements in culture 64 
medium formulations and the use of physiological oxygen environments, the rate of successful 65 
pregnancy after embryo culture remains considerably low. In 2014, the average live birth rate per 66 
IVF cycle for women in Canada was 23% (CFAS, 2015). One possible reason for this low 67 
success rate is the preimplantation embryo may be exposed to stress not normally encountered in 68 
vivo as a result of adverse culturing conditions (Feuer and Rinaudo, 2012; Wale and Gardner, 69 
2015). The mammalian preimplantation embryo may adapt to these adverse culture conditions, 70 
however, these stress induced responses can result in major changes to gene expression, 71 
epigenetic modifications, and cellular metabolism (Rinaudo and Schultz, 2004; Wale and 72 
Gardner, 2012; de Waal et al., 2014). These changes are currently undetectable by 73 
morphological non-invasive assessment methods, and thus embryos selected by morphology for 74 
transfer may still not be the most developmentally competent. This is a particular concern in 75 
current efforts to reduce multiple pregnancies by single embryo transfer (Grady et al., 2012). 76 
To further advance embryo culture and optimize culture parameters, it is important to 77 
understand the biological mechanisms of the preimplantation embryo and its interactions with 78 
the maternal and in vitro environment. Metabolism has emerged as an important research avenue 79 
in efforts to understand how culture conditions affect the developmental competence of early 80 
embryos (Gardner et al., 2001; Seli et al., 2010; Wale and Gardner, 2013). Modulating oxygen 81 
tension during embryo culture alters glucose metabolism, demonstrating that the culture 82 
atmosphere can dramatically influence embryo metabolism and subsequent viability (Wale and 83 
Gardner, 2012). This may affect the later stages of development in particular, as the 84 
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trophectoderm must generate ATP to power the Na
+
/K
+
 ATPases and form the blastocoele cavity 85 
(Betts et al., 1998; Houghton et al., 2003). The adaptor protein p66Shc is responsive to oxygen 86 
tension and is involved in the bovine embryo’s oxidative stress response by promoting 87 
permanent embryo arrest and apoptosis under adverse environmental conditions (Favetta et al., 88 
2007a; Betts et al., 2014). P66Shc is a member of the Shc1 family of proteins with functions in 89 
growth factor receptor signaling, reactive oxygen species (ROS) production, and oxidative 90 
phosphorylation metabolism (Migliaccio et al., 1997, 1999; Nemoto et al., 2006; Acin-Perez et 91 
al., 2010). Loss-of-function studies in mouse embryonic fibroblasts (MEFs) and more recently in 92 
HeLa cells provide evidence that p66Shc is involved in ATP production by oxidative 93 
phosphorylation (Nemoto et al., 2006; Soliman et al., 2014). Dysregulated p66Shc function in 94 
the mammalian embryo may therefore not only negatively impact development through high 95 
ROS production inducing embryo arrest or apoptosis (Favetta et al., 2004, 2007b; Betts et al., 96 
2014), but may also affect cellular metabolism (Favetta et al., 2007a). 97 
To  define a new metabolic route in which  preimplantation embryo culture may affect 98 
early embryonic development, the objective of our study sought to determine if p66Shc 99 
expression changes in cultured embryos compared to in vivo derived embryos, and if altered 100 
p66Shc expression is a marker of altered embryo metabolism. In the following study, we use a 101 
well-defined preimplantation mouse embryo culture model to modulate atmospheric conditions 102 
(oxygen) and culture media (glucose concentration) to determine their effects on p66Shc 103 
expression and readouts of oxidative phosphorylation metabolism. Our outcomes demonstrate 104 
preimplantation developmental variations in p66Shc expression that are further exacerbated by 105 
culture and correlate with aberrant mitochondrial ATP and ROS production.  106 
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Materials and Methods 107 
Animal Source and Ethical Approval 108 
Experimental protocols were approved by the Canadian Council of Animal Care and the 109 
University of Western Ontario Animal Care and Veterinary Services (Watson #2010-021). 110 
Female and male CD1 mice were obtained from Charles River Canada (St-Constant, Quebec, 111 
Canada). Mice were conventionally housed with a 12h light/dark cycle and had access to food 112 
and water ad libitum. or all experiments, mice were euthanized by CO2 asphyxiation.  113 
 114 
Embryo Collection and Culture 115 
Three-to-four week old female mice were injected intraperitoneal with 7.5 IU pregnant 116 
mare serum gonadotropin (Merck Animal Health, Canada) followed by injection of 7.5 IU 117 
human chorionic gonadotropin (Merck Animal Health, Canada) 48 hours later. Female mice 118 
were then placed with males for mating. Confirmation of mating was determined by checking for 119 
the presence of a vaginal plug the next morning; presence of a vaginal plug indicated embryonic 120 
day 0.5 (E0.5). Embryos were flushed with M2 medium (Sigma Aldrich, Canada) from the 121 
oviducts and/or uteri of female mice according to the time post injection (hpi): zygotes (18 hpi), 122 
2-cell embryos (44 hpi), 8-cell embryos (68 hpi) and blastocysts (90 hpi). Zygotes were briefly 123 
incubated in M2 medium containing 1% hyaluronidase (Sigma Aldrich, Canada) to remove 124 
cumulus cells. Embryos were washed twice in M2, then transferred to Extraction Buffer or 125 
radioimmunoprecipitation assay buffer (RIPA buffer, 150 mM NaCl, 1% Triton X-100, 0.5% 126 
sodium deoxycholate, 0.1% SDS, 50 mM Tris) until analysis, or to pre-equilibrated KSOMaa 127 
Evolve medium supplemented with 1% bovine serum albumin (Zenith Biotech, USA). Embryos 128 
were cultured under low (5% O2) or high (in air) oxygen tensions in a 5% CO2, 37°C incubator. 129 
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For glucose experiments, D- or L-glucose (Sigma Aldrich, Canada) was added to KSOMaa 130 
Evolve to the desired concentration and embryos were cultured under low oxygen. For 131 
transcriptional inhibition experiments, 10 mg/ml α-amanitin (Sigma Aldrich, Canada) in water 132 
was diluted to 10 µg/ml in KSOMaa Evolve. 133 
 134 
Real time RT-qPCR 135 
Pools of twenty embryos collected from 1-3 mice were stored in Extraction Buffer (Life 136 
Technologies, USA) at -80°C until use. Total RNA was extracted using the PicoPure RNA 137 
isolation kit (Life Technologies, USA) according to the manufacturer’s guidelines. For glucose 138 
treatment experiments, 0.5 pg of exogenous luciferase mRNA (Promega, USA) was added to the 139 
extract prior to ethanol precipitation. Eluted RNA was reverse transcribed to cDNA using 140 
SuperScript III (Life Technologies, USA) according to manufacturer’s instructions, with final 141 
concentrations of 150 ng random hexamers (Life Technologies, USA) and 2 pmol p66Shc-142 
specific reverse primer (Table I). Real time qPCR was performed in a CFX384 thermocycler 143 
(BioRad, Canada) with each reaction containing 7 µl PerfeCTa SYBR Green 2X SuperMix 144 
(Quanta BioSciences, USA), 200 nM of forward and reverse primers (see Table I for all primer 145 
sequences) and 4 µl cDNA (equivalent to 0.25 embryo per reaction). PCR conditions are as 146 
follows: 95°C for 3 minutes, followed by 45 cycles of 95°C for 15 seconds, 59°C for 15 seconds, 147 
and 72°C for 30 seconds. Relative transcript abundance was determined using the delta-delta CT 148 
method using expression of Ppia and H2afz, or luciferase, for normalization (Mamo et al., 2007). 149 
To determine amplification specificity, PCR products after qPCR amplification of p66Shc in 150 
blastocyst cDNA were purified using the PureLink Quick Gel Extraction and PCR Purification 151 
Kit (Life Technologies, USA) according to manufacturer’s instructions. PCR products were 152 
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sequenced by the Robarts Research Institute DNA Sequencing Facility (London, Ontario, 153 
Canada). Amplified p66Shc PCR products displayed 96% sequence identity to Mus musculus src 154 
homology 2 domain-containing transforming protein C1 (Shc1), transcript variant 1 155 
(NM_001113331.2) after BLAST analysis (NCBI database), indicating specific amplification of 156 
the p66Shc isoform. 157 
 158 
Western Blot Analysis 159 
Pools of 30-50 embryos collected from 2-4 mice were stored in RIPA buffer containing 160 
protease and phosphatase inhibitor cocktails (Millipore, USA) at -80°C until use. Total protein 161 
lysates were resolved on a 4-12% Bis-Tris gel (Life Technologies) and transferred to a PVDF 162 
membrane (Millipore, USA). Membranes were blocked in 5% skim milk or 5% bovine serum 163 
albumin in PBS with 0.1% Tween-20 (PBST, Sigma Aldrich) for 1 hour at room temperature, 164 
followed by overnight incubation in primary antibody at the indicated concentration at 4°C. 165 
Primary antibodies used: anti NT-Shc (Acris Antibodies, USA, 1:100), anti-(phospho S36) 166 
p66Shc (Abcam, USA, 1:100), anti-(phospho Y239/Y240) p66Shc (Cell Signaling Technologies, 167 
USA, 1:500), and HRP-conjugated anti β-actin (Sigma Aldrich, Canada, 1:20,000). Membranes 168 
were then incubated in HRP-conjugated secondary antibody (Jackson Laboratories, USA). 169 
Membranes were visualized by detection of Forte ECL (Millipore, USA). Densitometry analysis 170 
was performed in Image Lab 4.0 (BioRad, USA).  171 
 172 
HT-22 culture and transfection 173 
The HT-22 cell line (immortalized mouse hippocampal cells) and human p66Shc-HA 174 
expression plasmid were obtained from Dr. Robert Cumming (University of Western Ontario, 175 
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London, Canada). Cells were cultured in DMEM supplemented with 10% fetal bovine serum and 176 
1% penicillin/streptomycin (Life Technologies, USA), at 37°C and 5% CO2 in air. Cells were 177 
transfected with the p66Shc-HA expression plasmid using Lipofectamine 3000 according to the 178 
manufacturer’s protocol (Life Technologies, USA), fixed in 4% paraformaldehyde in PBS and 179 
processed for immunofluorescence and confocal microscopy. 180 
 181 
Immunofluorescence and Confocal Microscopy 182 
Embryos were fixed in 2% paraformaldehyde in PBS and permeabilized in 0.1% Triton 183 
X-100 in PBS (Sigma Aldrich, Canada) for 30 minutes. Fixed cells were blocked in 5% normal 184 
goat serum (Sigma Aldrich, Canada) for one hour at room temperature, followed by overnight 185 
incubation in primary antibody at the indicated concentration at 4°C. Primary antibodies used: 186 
anti NT-Shc (Acris Antibodies, 1:100), anti phospho-S36-p66Shc (Abcam, 1:100), anti CDX2 187 
(Abcam, 1:100), anti HA-Alexa 647 (Santa Cruz, USA, 1:50). Embryos were incubated in rabbit-188 
anti-mouse Alexa 488 (Life Technologies) for 30 minutes, followed by incubation in goat-anti-189 
rabbit Alexa 488 (Life Technologies) for signal amplification. For CDX2 immunoreactivity, 190 
embryos were incubated in goat-anti-rabbit Alexa 547 (Life Technologies). Cells were 191 
counterstained with 0.5 µg/ml DAPI (Sigma Aldrich, Canada) and mounted on a glass 192 
microscope slide in VectaShield antifade medium (Vector Laboratories, USA). Cells were 193 
imaged with a laser scanning confocal microscope (Zeiss LSM510). Laser settings were 194 
unchanged when detecting the same primary antibody.  195 
 196 
ATP content assay 197 
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10 
Pools of 5 blastocysts collected from individual mice after treatment under each oxygen 198 
tension group were transferred to 96-well plates containing KSOMaa Evolve. ATP content was 199 
measured using the Luminescent ATP Detection Assay Kit (Abcam, USA) according to 200 
manufacturer’s guidelines. Luminescence was quantified using an eight-point ATP standard 201 
curve (0.78 pmol to 100 pmol) and normalized to blastocyst cell number. 202 
 203 
MitoSOX superoxide staining 204 
Blastocysts from each oxygen tension group were transferred to KSOMaa Evolve 205 
containing 5 µM MitoSOX red mitochondrial superoxide indicator (Life Technologies, USA) 206 
and incubated for 1 hour at 37°C, 5% CO2, 5% O2 (in vivo and low oxygen groups) or in air 207 
(high oxygen groups). Blastocysts were transferred to a drop of PBS covered by embryo culture 208 
grade mineral oil (Zenith Biotech, USA) for imaging. Blastocysts were imaged using laser 209 
scanning confocal microscopy (Zeiss LSM510). Relative fluorescence was quantified by 210 
measuring the mean gray value in Image J (NIH). Only blastocyst images with visible inner cell 211 
mass were quantified for fluorescence and compared between groups. 212 
 213 
Blastocyst Cell Counts 214 
 Blastocysts were fixed in 4% paraformaldehyde in PBS, permeabilized in 0.2% Triton X-215 
100 in PBS, and stained with DAPI for 1 hour at room temperature. Stained blastocysts were 216 
imaged using laser scanning confocal microscopy, with three z-stacks taken per embryo. DAPI-217 
positive nuclei from three stacks were counted using ImageJ. 218 
 219 
Statistical Analyses 220 
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11 
Experiments were performed a minimum of three times using independent replicates with 221 
the indicated sample sizes. Statistical analyses were performed in Graph Pad Prism (6.0) for 222 
Student’s t-test (unpaired, two-tailed, equal variance) or one-way analysis of variance (ANOVA) 223 
followed by Tukey’s honestly significant difference (HSD) test to correct for multiple 224 
comparisons. Values presented in figures are the mean ± the standard error of the mean (SEM). 225 
Probability values less than 0.05 (p < 0.05) were considered statistically significant. 226 
  227 
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12 
Results 228 
P66Shc expression increases in blastocysts during mouse preimplantation development 229 
P66Shc expression has been previously detected in bovine (Favetta et al., 2004) and 230 
murine embryos (Ren et al., 2014), but an analysis of expression during the progression of 231 
mouse preimplantation development in vivo has not been carried out. To determine the 232 
expression profile of p66Shc during preimplantation development, we performed real time RT-233 
qPCR and immunoblotting on pools of embryos from four developmental stages. P66Shc 234 
transcript and protein were detectable in all stages observed. We observed a significant increase 235 
in both transcript and protein abundance from the 8-cell to blastocyst stages (Figure 1A, B). To 236 
determine the cellular localization of p66Shc during preimplantation development, we performed 237 
whole mount immunofluorescence followed by confocal microscopy using a p66Shc-specific 238 
antibody on embryos from six developmental stages. We observed p66Shc immunoreactivity 239 
throughout the cytoplasm of pre-compaction stage embryos (Figure 2A-D), with restriction to the 240 
apical cell periphery of compacted 16 cell morulae (Figure 2E). To determine if p66Shc 241 
localization is restricted to the trophectoderm lineage, we co-stained blastocysts with CDX2. Of 242 
all blastocysts observed, p66Shc showed detectable cell periphery localization in only CDX2 243 
positive cells. P66Shc immunoreactivity was undetectable in CDX2 negative cells (Figure 2F). 244 
These results indicate that p66Shc expression is normally upregulated in the blastocyst and may 245 
be restricted primarily to the trophectoderm of in vivo produced blastocysts. 246 
 247 
Validation of NT-Shc antibody specificity 248 
 To verify that the antibodies used to detect p66Shc and phosphorylated (S36) p66Shc  249 
only recognized the 66-kDa Shc isoform by immunofluorescence confocal microscopy, we  250 
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cultured mature neurons known to have undetectable basal p66Shc expression (Ventura et al., 251 
2002). We performed immunofluorescence using both antibodies on the mouse HT-22 252 
hippocampal cell line. HT-22 cells transfected with a HA-tagged p66Shc DNA construct showed 253 
p66Shc and HA immunoreactivity, while non-transfected cells showed no detectable p66Shc or 254 
HA immunoreactivity (Supplemental Figure 1A). Transfected HT-22 cells also displayed 255 
phosphorylated S36 p66Shc and HA immunoreactivity compared to undetectable levels in non-256 
transfected cells (Supplemental Figure 1B). These results validate the use of these antibodies for 257 
immunofluorescent detection of p66Shc and S36-phosphorylated p66Shc cell localization in 258 
mouse preimplantation embryos. 259 
 260 
P66Shc expression is sensitive to oxygen tension, but not glucose concentration, during 261 
embryo culture 262 
Under in vivo conditions, p66Shc expression levels may be fine-tuned to prevent adverse 263 
developmental events. Given our observations within in vivo derived mouse embryos, we then 264 
aimed to determine whether certain embryo culture conditions induce aberrant changes in 265 
embryonic p66Shc expression levels. Mouse zygotes were cultured to three developmental stages 266 
under low oxygen tension (5% O2) or high oxygen tension (21% O2). Real time RT-qPCR was 267 
performed on pools of embryos to determine changes in p66Shc transcript abundance. 268 
Blastocysts examined after 96 hours of culture showed increasing p66Shc transcript abundance 269 
with increasing oxygen tension (Figure 3A). This increase was dependent on de novo 270 
transcription of p66Shc, as the increase in p66Shc abundance was abolished in blastocysts 271 
cultured at high oxygen tension in the presence of the transcriptional inhibitor α-amanitin 272 
(Figure 3B). It is interesting to note that some p66Shc transcripts were still detectable in treated 273 
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blastocysts, suggesting that maternally stored p66Shc may still be present at the blastocyst stage 274 
(Figure 3B). Overall, these observations suggest that p66Shc is actively transcribed by the 275 
embryo under atmospheric oxygen conditions. 276 
We next aimed to determine if p66Shc protein abundance also increased under culture 277 
and high oxygen. Immunoblotting for total p66Shc on pools of embryos showed a significant 278 
increase in p66Shc protein abundance in cultured blastocysts (Figure 4A). This induction of 279 
p66Shc expression was unique to the blastocyst stage, as p66Shc transcript abundance decreased 280 
and protein abundance was unchanged in cultured 2-cell and 8-cell embryos (Supplemental 281 
Figure 2A and B). We then saw that increasing oxygen tension significantly decreased the 282 
phosphorylated S36 p66Shc to total p66Shc ratio in blastocysts, suggesting a possible change in 283 
the mitochondrial fraction of p66Shc in cultured blastocysts (Figure 4B). Oxygen tension did not 284 
alter the phosphorylated Y239/Y240 p66Shc to total p66Shc ratio (Figure 4C).  These are two 285 
residues on Shc1 proteins that are known to be phosphorylated after interaction with receptor 286 
tyrosine kinases (Gotoh et al., 1997). This result suggests that the shift in the 66-kDa band seen 287 
in cultured blastocysts may be due to an alternative (e.g. Ser138, Y317) or novel post-288 
translational modification induced by culture. 289 
To determine if p66Shc cellular localization changed with embryo culture, cultured 290 
blastocysts were stained for p66Shc immunoreactivity and were compared to freshly flushed, in 291 
vivo derived blastocysts. Blastocysts cultured in high oxygen conditions showed an increase in 292 
p66Shc fluorescence intensity and detectable diffuse p66Shc staining in putative ICM cells, 293 
compared to in vivo and low oxygen cultured blastocysts (Figure 5A-C). To determine the 294 
localization of phosphorylated S36 p66Shc, cultured blastocysts were stained for phosphorylated 295 
S36 p66Shc immunoreactivity and compared to in vivo controls. Consistent with the 296 
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immunoblotting results, neither the fluorescence levels of phosphorylated S36 p66Shc nor its 297 
localization appeared to change between treatment groups. However, phosphorylated S36 298 
p66Shc did show a distinct cellular localization pattern compared to total p66Shc, showing 299 
cytoplasmic and nuclear immunoreactivity in the outer and inner cells of the blastocyst (Figure 300 
6A-C). In addition, phosphorylated S36 p66Shc was also detectable in inner cells of the in vivo 301 
produced blastocyst while total p66Shc was not, indicating that there may be differences in 302 
sensitivity between the two p66Shc antibodies (Figures 5A and 6A). The localization pattern 303 
suggests that the phosphorylated S36 p66Shc fraction in blastocysts produced in vivo or in 304 
culture may be localized to a distinct compartment in the cytoplasm or nucleus compared to non-305 
phosphorylated, or p66Shc phosphorylated at a different residue.  306 
In addition to its role in mediating the oxidative stress response, several studies have 307 
implicated p66Shc in regulating cellular glucose uptake through growth factor receptor signaling, 308 
actin cytoskeleton regulation, or modulation of anaerobic respiration (Natalicchio et al., 2009; 309 
Soliman et al., 2014). Thus, we next aimed to determine if p66Shc expression is sensitive to 310 
medium glucose concentration, another component modified in embryo culture to simulate in 311 
vivo microenvironmental conditions. We cultured 8-cell stage embryos for 24 hours in KSOM 312 
varying in glucose concentrations under low oxygen tension: 0.2 mM (standard KSOM), 3.4 mM 313 
(equivalent to normal mouse oviductal glucose levels, (Gardner and Leese, 1990)), 30 mM D-314 
glucose (hyperglycemia, (Moley et al., 1998)) and 30 mM L-glucose to control for increased 315 
osmolarity. We observed that embryos cultured in 30 mM D-glucose have decreased rates of 316 
blastocyst cavitation (Figure 7A). The embryos did not fail to cavitate due to glucose toxicity, as 317 
18 hours culture in 0.2 mM D-glucose rescued cavitation (Figure 7B). Furthermore, cell number 318 
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in non-cavitated embryos did not significantly change with high glucose culture compared to 319 
control, suggesting that these embryos were not developing slower than the controls (Figure 7C).  320 
To determine if p66Shc expression changed during culture in high glucose, we performed 321 
RT-qPCR and immunoblotting for p66Shc in pools of blastocysts cultured in the four glucose 322 
concentrations. Neither transcript levels nor protein abundance significantly changed in embryos 323 
cultured in varying glucose conditions (Figure 8A-B), suggesting that p66Shc expression levels 324 
are not sensitive to increased glucose in embryo culture media. To determine if p66Shc cellular 325 
localization changed with glucose concentration, embryos cultured in 30 mM D-glucose were 326 
stained for p66Shc immunoreactivity and compared to embryos cultured in KSOM. We saw 327 
comparable peripheral and cytoplasmic p66Shc immunoreactivity in non-cavitated embryos after 328 
high glucose culture compared to controls, suggesting that p66Shc cellular localization is not 329 
impacted by media glucose concentrations (Figure 8C). 330 
 331 
Changes to p66Shc expression in culture correlate with altered embryo metabolism 332 
 To determine if increased p66Shc expression levels in cultured embryos could be a 333 
marker of altered embryo metabolism, we performed two metabolic assays on blastocysts 334 
derived in vivo and after culture under low and high oxygen. We first assessed total ATP content 335 
of blastocysts from each group, and observed that ATP levels per cell significantly decreased in 336 
blastocysts cultured under low oxygen compared to in vivo blastocysts (Figure 9A). As oxidative 337 
phosphorylation in the trophectoderm is the major source of cellular ATP in the blastocyst 338 
(Houghton, 2006), we then assayed for production of superoxide in the same treatment groups. 339 
Superoxide is a free radical produced as a by-product of oxidative phosphorylation that is 340 
normally present at low levels and is readily scavenged by superoxide dismutase. Blastocysts 341 
Page 16 of 47
http://molehr.oxfordjournals.org/
Draft Manuscript Submitted to MHR for Peer Review
For Review Only
 
 
17 
were incubated in MitoSOX red superoxide indicator and imaged using confocal microscopy. 342 
We observed that blastocysts cultured under low and high oxygen showed significantly higher 343 
MitoSOX fluorescence compared to in vivo controls, suggesting increased superoxide production 344 
or decreased antioxidant scavenging in these culture conditions (Figure 9B). Our results suggest 345 
that even under low oxygen conditions, cultured blastocysts contain less ATP and increased 346 
superoxide levels, correlating with increased mRNA and protein abundance of p66Shc. 347 
  348 
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Discussion 349 
 Here we demonstrate that p66Shc is basally expressed in mouse preimplantation embryos 350 
and its expression is altered by embryo culture. We also show that dysregulated p66Shc 351 
expression coincides with metabolic changes in culture that may negatively affect embryo 352 
developmental viability. Our results suggest that p66Shc is an oogenetic-stored transcript that is 353 
degraded during the maternal-to-embryonic transition, later upregulated by the blastocyst stage, 354 
and predominately located at the cell periphery of trophectoderm cells. Blastocysts grown in 355 
vitro show increasing p66Shc expression with increasing oxygen tension, coupled with 356 
alterations to phosphorylated residues that have implications in the protein’s cellular 357 
compartmentalization and function. These changes appear to be oxygen-sensitive, while 358 
changing media glucose concentrations did not significantly affect p66Shc expression levels in 359 
the blastocyst. Lastly, we are the first to correlate these changes in culture and high oxygen 360 
tension to dysregulated ATP and superoxide production within in vitro produced blastocysts.   361 
Our expression analysis of p66Shc during in vivo blastocyst development suggests that 362 
p66Shc is normally upregulated during the eight-cell embryo to blastocyst transition. This basal 363 
level of expression during in vivo development implies that despite promoting apoptosis, p66Shc 364 
expression maybe necessary for survival and prevent blastocysts from being selected against 365 
during development. One possible biological function of p66Shc during preimplantation 366 
development may be the promotion of oxidative phosphorylation. Basal oxygen consumption in 367 
66Shc-null MEFs decreases by 30-50% with no change in mitochondrial or cytochrome c 368 
content, with a compensatory increase in ATP production by anaerobic respiration (Nemoto et 369 
al., 2006).  There is also evidence suggesting that in MEFs, p66Shc forms a complex with 370 
cytochrome c in the inner mitochondrial membrane to regulate pyruvate dehydrogenase kinase 371 
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(PDK), ultimately regulating the activity of pyruvate dehydrogenase (PDH) depending on the 372 
redox state of cytochrome c (Acin-Perez et al., 2010). In the mouse blastocyst, the trophectoderm 373 
produces ATP through oxidative phosphorylation to support development, but the ICM is 374 
relatively metabolically quiescent (Houghton, 2006). Metabolic differences between the two 375 
embryonic linages could account for our immunolocalization results, as p66Shc appears to 376 
localize predominately to the trophectoderm in vivo and under low oxygen conditions, 377 
suggesting that p66Shc could be involved in trophectoderm metabolism.  Although our study did 378 
not directly test the role of p66Shc in oxidative phosphorylation, we have correlated increasing 379 
p66Shc transcript and protein abundances after embryo culture with alterations to ATP and 380 
superoxide production, suggesting that dysregulated p66Shc levels in the embryo may have a 381 
negative impact on embryo metabolism.  382 
Studies of p66Shc in mammalian embryos have thus far focused primarily on the 383 
apoptosis- and senescence-promoting functions of p66Shc, basally or in stress-inducing culture 384 
conditions. In bovine preimplantation embryos, siRNA-mediated knockdown of p66Shc reduces 385 
levels of intracellular ROS, DNA damage, and apoptosis in untreated and oxidant-treated culture 386 
conditions (Betts et al., 2014). Bovine preimplantation embryos exhibit high levels of 387 
developmental arrest (>50%) in culture (Leidenfrost et al., 2011), likely due to suboptimal 388 
culture conditions, which could result in increased p66Shc transcript levels, leading to 389 
senescence (permanent embryo arrest) and apoptosis. Due to species-specific differences in early 390 
development, or better optimized conditions, mouse preimplantation embryos from inbred strains 391 
exhibit high developmental rates with >75% of zygotes reaching the blastocyst stage in 392 
optimized media and low oxygen conditions (Karagenc et al., 2004). It is possible that p66Shc 393 
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expression is carefully regulated during preimplantation development, such that both abnormally 394 
high and low p66Shc expression levels are detrimental to the embryo.  395 
Consistent with our findings in our mouse embryo culture model, there is strong evidence 396 
associating p66Shc induction under adverse embryo culture conditions. Bovine embryos under 397 
oviductal epithelial cell co-culture growth conditions show significantly increased p66Shc 398 
transcript abundance compared to culture under chemically defined synthetic oviductal fluid 399 
media at lower oxygen tension. This increase was associated with increased markers of oxidative 400 
stress (intracellular ROS, DNA damage) and embryo arrest (Favetta et al., 2007b). Mouse 401 
embryos treated with arsenic show increasing p66Shc immunofluorescence intensity, suggesting 402 
that p66Shc may mediate a stress response to arsenic (Zhang et al., 2010). Preimplantation 403 
development under both cases improved when p66Shc was knocked down by RNA interference 404 
(Favetta et al., 2007a; Betts et al., 2014; Ren et al., 2014).  Previous RNA-interference 405 
experiments may have normalized an adverse environment-induced “spike” in p66Shc 406 
expression, but not completely deplete the embryo of maternal- or zygotic-derived p66Shc, thus 407 
masking any loss-of-function phenotype. Maternally-derived p66Shc function may be important 408 
to preimplantation development, as embryo cleavage and blastocyst development is impaired 409 
when p66Shc is knocked down in immature bovine oocytes (Favetta et al., 2007a). We are the 410 
first to show that p66Shc transcript and protein expression is upregulated at the blastocyst stage 411 
during mouse in vivo development, indicating that p66Shc may also have an important 412 
physiological function other than promoting apoptosis and embryo arrest. 413 
 The induction of p66Shc transcription in cultured blastocysts appears to be specific to 414 
oxygen, as increasing media glucose concentrations did not significantly change p66Shc 415 
transcript abundance compared to controls. Oxygen-sensitive induction in our results is 416 
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consistent with findings that p66Shc transcription can be regulated by the Nrf2-antioxidant 417 
response element (ARE) pathway under stress-inducing conditions. Chromatin 418 
immunoprecipitation assays performed in hemin-treated human erythroleukemic cells 419 
demonstrated that Nrf2 binds to an ARE enhancer upstream of the transcriptional start site of 420 
p66Shc and that Nrf2 induction of expression is isoform-specific (Miyazawa and Tsuji, 2014). 421 
This could be the upstream mechanism in our model of p66Shc transcriptional upregulation in 422 
blastocysts cultured under high oxygen. High media glucose concentrations did not significantly 423 
change p66Shc expression in blastocysts, but did affect cavitation. This is consistent with 424 
previous reports of hyperglycemic conditions negatively affecting blastocyst development 425 
(Fraser et al., 2007). Thus it is unlikely that the cell’s response to high glucose regulates the 426 
transcription of p66Shc, but instead may affect other genes known to be involved in cavitation 427 
(e.g. Atp1b1, Aqp3, Aqp9, Cdh1). Furthermore, it is not known whether p66Shc is important for 428 
the regulation of glucose uptake in preimplantation embryos or if this function is dependent on 429 
mTOR or growth factor receptor signaling pathways (Natalicchio et al., 2009; Soliman et al., 430 
2014). It is possible that p66Shc could mediate a response to high glucose levels in embryos 431 
independent of an increase in its transcript or protein abundance, through phosphorylation of 432 
certain residues.  433 
It is possible that culture conditions increase p66Shc expression to promote its apoptotic 434 
functions, removing it from its metabolic function in the mitochondria. Our results suggest that 435 
culture-mediated changes to phosphorylated residues on p66Shc may impact its cellular 436 
compartmentalization and may ultimately be a key factor in its cellular function. Subcellular 437 
fractionation of untreated MEF lysates showed that p66Shc is detectable in the soluble, 438 
mitochondrial, and endoplasmic reticulum fractions (Orsini et al., 2004). Phosphorylation of the 439 
Page 21 of 47
http://molehr.oxfordjournals.org/
Draft Manuscript Submitted to MHR for Peer Review
For Review Only
 
 
22 
serine-36 residue, which is unique to the 66 kDa isoform of the Shc1 family, has been implicated 440 
in its cellular localization. Serine-36 phosphorylation of p66Shc under oxidizing conditions 441 
increases its association with the prolyl isomerase Pin-1, ultimately resulting in p66Shc 442 
translocation to the mitochondria. Fibroblasts lacking Pin-1 have a decreased mitochondrial 443 
fraction of p66Shc after H2O2 treatment compared to wild type fibroblasts, linking the 444 
modification of this residue to the protein’s mitochondrial localization (Pinton et al., 2007). In 445 
our study, blastocysts cultured under low or high oxygen conditions show decreased 446 
phosphorylated 36 to total p66Shc ratios, suggesting that these conditions may decrease the 447 
mitochondrial fraction of p66Shc despite an increase in total p66Shc protein abundance. This 448 
alteration in cellular localization may affect p66Shc’s functions in the mitochondria, which our 449 
results of altered embryo metabolism may reflect.  450 
 Despite using optimal culture conditions, both p66Shc expression and the metabolic 451 
parameters measured were significantly altered in blastocysts grown under low oxygen tension. 452 
No significant difference between increased superoxide production in blastocysts after culture in 453 
low or high oxygen tension suggests that oxidative phosphorylation metabolism may be 454 
adversely affected regardless of oxygen tension, or that there is another parameter in the 455 
microenvironment that must be further optimized to limit metabolic alterations in cultured 456 
embryos. Levels of p66Shc may therefore be an indicator of altered blastocyst metabolism, 457 
particularly of the trophectoderm, which is responsible for generating nearly all of the 458 
blastocyst’s ATP content (Houghton, 2006). Altered expression levels and/or p66Shc function in 459 
culture may lead to adverse trophectoderm development through increases in ROS-mediated 460 
apoptosis or decreases in ATP production, which may impact implantation and placentation. Our 461 
study did not follow up on peri- and post-implantation stage embryos and p66Shc expression 462 
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levels, but we suspect that p66Shc expression is likely altered in the trophoblast or post-463 
implantation trophoblast-derived tissues after embryo culture. Supporting this is evidence that 464 
p66Shc CpG promoter methylation is decreased in human placental tissue of intrauterine growth 465 
restricted neonates compared to neonates appropriate and small for gestational age (Tzschoppe et 466 
al., 2013). This is also consistent with the finding most culture-induced embryo abnormalities 467 
affect the trophoblast and placenta, and to a lesser extent the fetal tissues (Fauque et al., 2010; de 468 
Waal et al., 2014).  For clinical applications, using increased p66Shc expression as a molecular 469 
marker of altered metabolism may impact which blastocyst may be the most developmentally 470 
competent for embryo transfer. 471 
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Figure Legends 602 
Figure 1. p66Shc expression increases during mouse preimplantation development in vivo. (A) 603 
RT-qPCR for p66Shc relative transcript abundance was performed on three replicates of pools of 604 
20 embryos per stage. P66Shc relative transcript abundance significantly increases from eight 605 
cell to blastocyst-stage embryos (n=3, mean ± SEM, p=0.0476 1W-ANOVA). (B) 606 
Immunoblotting for total p66Shc protein abundance was performed on three replicates of pools 607 
of 30-50 embryos per stage. P66Shc relative protein abundance increases from eight cell to 608 
blastocyst-stage embryos (n=3, mean ± SEM, p=0.0331 1W-ANOVA). A representative blot is 609 
shown. 610 
 611 
Figure 2. p66Shc progressively localizes to the cell periphery during mouse preimplantation 612 
development. Immunofluorescence and confocal microscopy for p66Shc was performed on 10-613 
20 embryos per stage. Representative confocal images are shown: (A) Zygote (B) 2-cell embryo 614 
(C) 4-cell embryo (D) 8-cell non-compacted embryo (E) 8-16 cell compacted morula (F) 615 
Blastocyst, counterstained for CDX2 (G) Primary antibody omitted. Green = p66Shc, Red = 616 
CDX2, Blue = DAPI. Scale bar = 20 µm.  617 
 618 
Figure 3. Culture and high oxygen tension increases the relative p66Shc mRNA abundance in 619 
blastocysts. (A) RT-qPCR for p66Shc was performed on four replicates of pools of 20 620 
blastocysts. There is a significant increase in p66Shc mRNA abundance in blastocysts cultured at 621 
high oxygen tension compared to in vivo controls (n=4, mean ± SEM, p=0.0305 1W-ANOVA). 622 
(B) Blastocysts cultured for 24h in 10 µg/ml α-amanitin showed significantly decreased p66Shc 623 
transcript abundance compared to controls (n=3, mean ± SEM, p=0.0477 Student’s t-test). 624 
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 625 
Figure 4. Culture and high oxygen tension increases the relative p66Shc protein abundance in 626 
blastocysts. (A) Immunoblotting for p66Shc was performed on four replicates of pools of 50 627 
blastocysts. P66Shc protein abundance significantly increases in blastocysts cultured at low 628 
oxygen tension compared to in vivo controls (n=4, mean ± SEM, p=0.0306 1W-ANOVA). A 629 
representative blot is shown. (B) Immunoblotting for phosphorylated p66Shc on serine 36 (S36) 630 
and total p66Shc was performed on three replicates of pools of 40-50 blastocysts. The ratio of 631 
phospho (S36)-p66Shc:total p66Shc significantly decreases in cultured blastocysts compared to 632 
controls (n=3, mean ± SEM, p=0.0057 for low O2; p=0.0219 for high O2 1W-ANOVA). A 633 
representative blot is shown. (C) Immunoblotting for phosphorylated Y239/Y240-p66Shc and 634 
total p66Shc was performed on three replicates of pools of 20-30 blastocysts. The ratio of 635 
phosphor Y239/Y240-p66Shc:total p66Shc does not significantly in cultured blastocysts 636 
compared to controls (n=3, mean ± SEM, p=0.5043, 1W-ANOVA). A representative blot is 637 
shown. 638 
 639 
Figure 5. Total p66Shc becomes detectable in the inner cells of blastocysts cultured under 640 
atmospheric oxygen tension. Representative immunofluorescence and confocal microscopy 641 
images for total p66Shc in pools of 10-15 blastocysts per treatment group. (A) In vivo flushed 642 
blastocysts. (B) Blastocysts after 96 h culture under low oxygen tension. (C) Blastocysts after 96 643 
h culture under high oxygen tension. Green = p66Shc, Blue = DAPI. Scale bar = 20 µm. 644 
 645 
Figure 6. Phosphorylated S36 p66Shc localization does not change in cultured blastocysts. 646 
Representative immunofluorescence and confocal microscopy images for phosporylated (S36) 647 
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p66Shc in pools of 15-20 blastocysts per treatment group. (A) In vivo flushed blastocysts. (B) 648 
Blastocysts after 96 h culture under low oxygen tension. (C) Blastocysts after 96 h culture under 649 
high oxygen tension. Green = p66Shc, Blue = DAPI. Scale bar = 20 µm. 650 
 651 
Figure 7. High glucose media concentrations reversibly inhibit embryo cavitation. (A) Percent 652 
cavitation of blastocysts after 24h culture in each treatment group, indicated by the formation of 653 
any cavity in the embryo (n=4, mean ± SEM, p=0.0052 1W-ANOVA). (B) Bright field 654 
microscopy images of embryos after 24h treatment in 30 mM D-glucose, followed by recovery 655 
in low glucose KSOM for 18 hours. Arrows in the left panel indicate examples of embryos 656 
classified as non-cavitated. Thirteen of sixteen non-cavitated embryos after high glucose 657 
treatment cavitated after 18 hours of recovery. (C) Blastocyst cell number after 24h culture in 658 
each treatment group (n=19-21 per group, mean ± SEM, p=0.5099 1W-ANOVA). 659 
 660 
Figure 8. High glucose media concentrations do not significantly change relative p66Shc mRNA 661 
and protein abundance in blastocysts. (A) qRT-PCR was performed on pools of 10 blastocysts 662 
for relative p66Shc transcript abundance, normalized to levels of exogenously added luciferase 663 
(n=3, mean ± SEM, p=0.3783 1W-ANOVA). (B) Immunoblotting was performed on pools of 30 664 
blastocysts per treatment group for total p66Shc protein abundance, normalized to levels of β-665 
actin. A representative blot is shown (n=3, mean ± SEM, p=0.5549 1W-ANOVA). (C) 666 
Representative immunofluorescence and confocal microscopy images of blastocysts cultured in 667 
30 mM D-glucose (right panel) and KSOM only (left panel) for total p66Shc reactivity. Green = 668 
p66Shc, Blue =DNA. Scale bar = 20 µm. 669 
 670 
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Figure 9. Increased p66Shc expression correlates with decreased ATP and increased superoxide 671 
in cultured blastocysts. (A) Total ATP content was quantified from pools of 5 blastocysts in each 672 
treatment group and normalized to blastocyst cell number. ATP content per cell significantly 673 
decreases in blastocysts cultured in low oxygen for 96h compared to in vivo controls (n=3, mean 674 
± SEM, p=0.0.0199 1W-ANOVA). Mean cell numbers for each treatment group are: in vivo = 675 
27.43 ± 10.31 (n=46), low oxygen = 35.03 ± 7.36 (n=31), high oxygen = 31.41 ± 9.49 (n=30). 676 
(B) MitoSOX relative fluorescence was quantified in blastocysts in each treatment group. 677 
MitoSOX fluorescence significantly increases in blastocysts cultured under low or high oxygen 678 
compared to in vivo controls (in vivo n=28, low oxygen n=26, high oxygen n=23, mean ± SEM, 679 
p<0.0001 1W-ANOVA). Representative images of MitoSOX staining are shown in the three 680 
panels. 681 
 682 
Supplemental Figure 1. NT-Shc and phosphorylated S36 p66Shc antibody validation for 683 
immunofluorescence and confocal microscopy. (A) Immunofluorescence and confocal 684 
microscopy images of p66Shc-HA transfected HT-22 cells (left) and non-transfected cells 685 
(right). Green = total p66Shc, Red = HA, Blue = DAPI. Scale bar = 50 µm. (B) Images of 686 
p66Shc-HA transfected HT-22 cells (left) and non-transfected cells (right). Green = pSer36-687 
p66Shc, Red = HA, Blue = DAPI. Scale bar = 50 µm. 688 
 689 
Supplemental Figure 2. Relative p66Shc mRNA and protein abundance in cultured 2-cell and 690 
8-cell embryos. (A) qRT-PCR was performed on pools of 20 2-cell embryos for p66Shc relative 691 
transcript abundance. P66Shc transcript abundance significantly decreases with culture and 692 
increasing oxygen tension (n=4, mean ± SEM, p=0.0310 1W-ANOVA). Immunoblotting was 693 
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35 
performed on pools of 50 2-cell embryos for p66Shc relative protein abundance. A representative 694 
blot is shown (n=3, mean ± SEM, p=0.7256 1W-ANOVA). (B) qRT-PCR was performed on 695 
pools of 20 8-cell embryos for p66Shc relative transcript abundance, which significantly 696 
decreases with culture and increasing oxygen tension (n=4, mean ± SEM, p=0.0004 1W-697 
ANOVA). Immunoblotting was performed on pools of 50 8-cell embryos for p66Shc relative 698 
protein abundance. A representative blot is shown (n=4, mean ± SEM, p=0.8375 1W-ANOVA).   699 
 700 
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Table I. Oligonucleotide Primer Sequences 
Expected 
product size 
p66Shc R (reverse 
transcription) 
5’-GGTGGATTCCTGAGATACTGTTT-3’ N/A 
p66Shc (qPCR) F: 5’-CCGACTACCCTGTGTTCCTTCTT-3’ 
R: 5’-CCCATCTTCAGCAGCCTTTCC-3’ 
111 bp 
Ppia F: 5’-GTCCTGGCATCTTGTCCATG-3’ 
R: 5’-TGCCTTCTTTCACCTTCCCA-3’ 
126 bp 
H2afz F: 5’-CGCAGAGGTACTTGAGTTGG-3’ 
R: 5’-TCTTCCCGATCAGCGATTTG-3’ 
176 bp 
Luciferase F: 5’-TTGACAAGGATGGATGGCTAC-3’ 
R: 5’-TTCGGTACTTCGTCCACCAAAC-3’ 
336 bp 
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Figure 1. p66Shc expression increases during mouse preimplantation development in vivo. (A) RT-qPCR for 
p66Shc relative transcript abundance was performed on three replicates of pools of 20 embryos per stage. 
P66Shc relative transcript abundance significantly increases from eight cell to blastocyst-stage embryos 
(n=3, mean  SEM, p=0.0476 1W-ANOVA). (B) Immunoblotting for total p66Shc protein abundance was 
performed on three replicates of pools of 30-50 embryos per stage. P66Shc relative protein abundance 
increases from eight cell to blastocyst-stage embryos (n=3, mean  SEM, p=0.0331 1W-ANOVA). A 
representative blot is shown.  
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Figure 2. p66Shc progressively localizes to the cell periphery during mouse preimplantation development. 
Immunofluorescence and confocal microscopy for p66Shc was performed on 10-20 embryos per stage. 
Representative confocal images are shown: (A) Zygote (B) 2-cell embryo (C) 4-cell embryo (D) 8-cell non-
compacted embryo (E) 8-16 cell compacted morula (F) Blastocyst, counterstained for CDX2 (G) Primary 
antibody omitted. Green = p66Shc, Red = CDX2, Blue = DAPI. Scale bar = 20 m.  
180x82mm (300 x 300 DPI)  
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Figure 3. Culture and high xygen tension increases the relative p66Shc mRNA abundance in blastocysts. 
(A) RT-qPCR for p66Shc was performed on four replicates of pools of 20 blastocysts. There is a significant 
increase in p66Shc mRNA abundance in blastocysts cultured at high oxygen tension compared to in vivo 
controls (n=4, mean  SEM, p=0.0305 1W-ANOVA). (B) Blastocysts cultured for 24h in 10 g/ml -amanitin 
showed significantly decreased p66Shc transcript abundance compared to controls (n=3, mean  SEM, 
p=0.0477 Student’s t-test).  
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Figure 4. Culture and high oxygen tension increases the relative p66Shc protein abundance in blastocysts. 
(A) Immunoblotting for p66Shc was performed on four replicates of pools of 50 blastocysts. P66Shc protein 
abundance significantly increases in blastocysts cultured at low oxygen tension compared to in vivo controls 
(n=4, mean  SEM, p=0.0306 1W-ANOVA). A representative blot is shown. (B) Immunoblotting for 
phosphorylated p66Shc on serine 36 (S36) and total p66Shc was performed on three replicates of pools of 
40-50 blastocysts. The ratio of phospho (S36)-p66Shc:total p66Shc significantly decreases in cultured 
blastocysts compared to controls (n=3, mean  SEM, p=0.0057 for low O2; p=0.0219 for high O2 1W-
ANOVA). A representative blot is shown. (C) Immunoblotting for phosphorylated Y239/Y240-p66Shc and 
total p66Shc was performed on three replicates of pools of 20-30 blastocysts. The ratio of phosphor 
Y239/Y240-p66Shc:total p66Shc does not significantly in cultured blastocysts compared to controls (n=3, 
mean  SEM, p=0.5043, 1W-ANOVA). A representative blot is shown.  
215x279mm (300 x 300 DPI)  
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Figure 5. Total p66Shc becomes detectable in the inner cells of blastocysts cultured under atmospheric 
oxygen tension. Representative immunofluorescence and confocal microscopy images for total p66Shc in 
pools of 10-15 blastocysts per treatment group. (A) In vivo flushed blastocysts. (B) Blastocysts after 96 h 
culture under low oxygen tension. (C) Blastocysts after 96 h culture under high oxygen tension. Green = 
p66Shc, Blue = DAPI. Scale bar = 20 µm.  
184x165mm (300 x 300 DPI)  
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Figure 6. Phosphorylated S36 p66Shc localization does not change in cultured blastocysts. Representative 
immunofluorescence and confocal microscopy images for phosporylated (S36) p66Shc in pools of 15-20 
blastocysts per treatment group. (A) In vivo flushed blastocystµs. (B) Blastocysts after 96 h culture under 
low oxygen tension. (C) Blastocysts after 96 h culture under high oxygen tension. Green = p66Shc, Blue = 
DAPI. Scale bar = 20 m.  
184x165mm (300 x 300 DPI)  
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Figure 7. High glucose media concentrations reversibly inhibit embryo cavitation. (A) Percent cavitation of 
blastocysts after 24h culture in each treatment group, indicated by the formation of any cavity in the 
embryo (n=4, mean  SEM, p=0.0052 1W-ANOVA). (B) Bright field microscopy images of embryos after 24h 
treatment in 30 mM D-glucose, followed by recovery in low glucose KSOM for 18 hours. Arrows in the left 
panel indicate examples of embryos classified as non-cavitated. Thirteen of sixteen non-cavitated embryos 
after high glucose treatment cavitated after 18 hours of recovery. (C) Blastocyst cell number after 24h 
culture in each treatment group (n=19-21 per group, mean  ±SEM, p=0.5099 1W-ANOVA).  
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Figure 8. High glucose media concentrations do not significantly change relative p66Shc mRNA and protein 
abundance in blastocysts. (A) qRT-PCR was performed on pools of 10 blastocysts for relative p66Shc 
transcript abundance, normalized to levels of exogenously added luciferase (n=3, mean  SEM, p=0.3783 
1W-ANOVA). (B) Immunoblotting was performed on pools of 30 blastocysts per treatment group for total 
p66Shc protein abundance, normalized to levels of β-actin. A representative blot is shown (n=3, 
mean  ±SEM, p=0.5549 1W-ANOVA). (C) Representative immunofluorescence and confocal microscopy 
images of blastocysts cultured in 30 mM D-glucose (right panel) and KSOM only (left panel) for total p66Shc 
reactivity. Green = p66Shc, Blue =DNA. Scale bar = 20 µm.  
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Figure 9. Increased p66Shc expression correlates with decreased ATP and increased superoxide in cultured 
blastocysts. (A) Total ATP content was quantified from pools of 5 blastocysts in each treatment group and 
normalized to blastocyst cell number. ATP content per cell significantly decreases in blastocysts cultured in 
low oxygen for 96h compared to in vivo controls (n=3, mean  ±SEM, p=0.0.0199 1W-ANOVA). Mean cell 
numbers for each treatment group are: in vivo = 27.43  10.31 (n=46), low oxygen = 35.03  7.36 (n=31), 
high oxygen = 31.41  9.49 (n=30). (B) MitoSOX relative fluorescence was quantified in blastocysts in each 
treatment group. MitoSOX fluorescence significantly increases in blastocysts cultured under low or high 
oxygen compared to in vivo controls (in vivo n=28, low oxygen n=26, high oxygen n=23, mean  ±SEM, 
p<0.0001 1W-ANOVA). Representative images of MitoSOX staining are shown in the three panels.  
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